P. David Rogers

8.8k total citations · 2 hit papers
109 papers, 6.5k citations indexed

About

P. David Rogers is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, P. David Rogers has authored 109 papers receiving a total of 6.5k indexed citations (citations by other indexed papers that have themselves been cited), including 94 papers in Infectious Diseases, 74 papers in Epidemiology and 16 papers in Molecular Biology. Recurrent topics in P. David Rogers's work include Antifungal resistance and susceptibility (94 papers), Fungal Infections and Studies (61 papers) and Pneumocystis jirovecii pneumonia detection and treatment (32 papers). P. David Rogers is often cited by papers focused on Antifungal resistance and susceptibility (94 papers), Fungal Infections and Studies (61 papers) and Pneumocystis jirovecii pneumonia detection and treatment (32 papers). P. David Rogers collaborates with scholars based in United States, Germany and United Kingdom. P. David Rogers's co-authors include Katherine S. Barker, Joachim Morschhäuser, Jeffrey M. Rybak, Sarah Whaley, Andrew T. Nishimoto, Elizabeth L. Berkow, Ramin Homayouni, Teresa T. Liu, John D. Cleary and Stanley W. Chapman and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and PLoS ONE.

In The Last Decade

P. David Rogers

105 papers receiving 6.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species

2017 657 citations Elizabeth L. Berkow, Jeffrey M. Rybak et al. profile →
Mechanisms of Antifungal Drug Resistance

2014 448 citations P. David Rogers et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P. David Rogers United States	44	4.8k	3.8k	1.5k	835	783	109	6.5k
Donna M. MacCallum United Kingdom	47	4.7k 1.0×	3.4k 0.9×	2.2k 1.5×	979 1.2×	367 0.5×	93	6.3k
Joachim Morschhäuser Germany	50	6.1k 1.3×	4.6k 1.2×	2.8k 1.9×	1.0k 1.2×	702 0.9×	165	8.2k
Richard Calderone United States	48	5.2k 1.1×	3.3k 0.9×	2.7k 1.9×	1.4k 1.6×	608 0.8×	186	7.4k
Jeniel E. Nett United States	47	5.8k 1.2×	3.5k 0.9×	2.7k 1.9×	576 0.7×	537 0.7×	82	7.4k
Karl V. Clemons United States	45	4.5k 0.9×	3.8k 1.0×	1.9k 1.3×	814 1.0×	391 0.5×	200	7.0k
Clarissa J. Nobile United States	43	6.2k 1.3×	3.7k 1.0×	3.0k 2.1×	807 1.0×	549 0.7×	110	8.3k
Francesco Barchiesi Italy	41	3.7k 0.8×	3.0k 0.8×	900 0.6×	478 0.6×	456 0.6×	160	5.6k
William A. Fonzi United States	35	4.8k 1.0×	3.1k 0.8×	3.0k 2.1×	1.2k 1.5×	462 0.6×	68	6.7k
Nicole Robbins Canada	31	2.8k 0.6×	1.9k 0.5×	1.3k 0.9×	650 0.8×	589 0.8×	71	4.2k
Françoise Ischer Switzerland	22	3.5k 0.7×	2.6k 0.7×	1.1k 0.7×	581 0.7×	507 0.6×	25	4.5k

Countries citing papers authored by P. David Rogers

Since Specialization

Citations

This map shows the geographic impact of P. David Rogers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. David Rogers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. David Rogers more than expected).

Fields of papers citing papers by P. David Rogers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. David Rogers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. David Rogers. The network helps show where P. David Rogers may publish in the future.

Co-authorship network of co-authors of P. David Rogers

This figure shows the co-authorship network connecting the top 25 collaborators of P. David Rogers. A scholar is included among the top collaborators of P. David Rogers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. David Rogers. P. David Rogers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rybak, Jeffrey M., et al.. (2024). Analysis of clinical Candida parapsilosis isolates reveals copy number variation in key fluconazole resistance genes. Antimicrobial Agents and Chemotherapy. 68(6). e0161923–e0161923. 5 indexed citations

Rybak, Jeffrey M., Jinhong Xie, Adela Martín‐Vicente, et al.. (2024). A secondary mechanism of action for triazole antifungals in Aspergillus fumigatus mediated by hmg1. Nature Communications. 15(1). 3642–3642. 22 indexed citations

Ramírez‐Zavala, Bernardo, et al.. (2024). Probing gene function in Candida albicans wild-type strains by Cas9-facilitated one-step integration of two dominant selection markers: a systematic analysis of recombination events at the target locus. mSphere. 9(7). e0038824–e0038824. 1 indexed citations

Rybak, Jeffrey M., Katherine S. Barker, José F. Muñoz, et al.. (2021). In vivo emergence of high-level resistance during treatment reveals the first identified mechanism of amphotericin B resistance in Candida auris. Clinical Microbiology and Infection. 28(6). 838–843. 77 indexed citations

Rybak, Jeffrey M., José F. Muñoz, Katherine S. Barker, et al.. (2020). Mutations in TAC1B : a Novel Genetic Determinant of Clinical Fluconazole Resistance in Candida auris. mBio. 11(3). 135 indexed citations

Nishimoto, Andrew T., Cheshta Sharma, & P. David Rogers. (2019). Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungusCandida albicans. Journal of Antimicrobial Chemotherapy. 75(2). 257–270. 75 indexed citations

Sasse, Christoph, et al.. (2011). The Transcription Factor Ndt80 Does Not Contribute to Mrr1-, Tac1-, and Upc2-Mediated Fluconazole Resistance in Candida albicans. PLoS ONE. 6(9). e25623–e25623. 47 indexed citations

Lis, Maciej, Teresa T. Liu, Katherine S. Barker, P. David Rogers, & Libuse A. Bobek. (2010). Antimicrobial peptide MUC7 12-mer activates the calcium/calcineurin pathway in Candida albicans. FEMS Yeast Research. 10(5). no–no. 18 indexed citations

Hoehamer, Christopher F., et al.. (2009). Upc2p‐associated differential protein expression in Candida albicans. PROTEOMICS. 9(20). 4726–4730. 7 indexed citations

10.

Talbert, Robert L., et al.. (2007). Increases in SLT2 Expression and Chitin Content Are Associated with Incomplete Killing of Candida glabrata by Caspofungin. Antimicrobial Agents and Chemotherapy. 52(3). 1144–1146. 61 indexed citations

11.

Morschhäuser, Joachim, et al.. (2007). The Transcription Factor Mrr1p Controls Expression of the MDR1 Efflux Pump and Mediates Multidrug Resistance in Candida albicans. PLoS Pathogens. 3(11). e164–e164. 260 indexed citations

12.

Rogers, P. David, Teresa T. Liu, Katherine S. Barker, et al.. (2007). Gene expression profiling of the response of Streptococcus pneumoniae to penicillin. Journal of Antimicrobial Chemotherapy. 59(4). 616–626. 69 indexed citations

13.

Rogers, P. David. (2006). Proteomic analysis of experimentally induced azole resistance in Candida glabrata. Journal of Antimicrobial Chemotherapy. 58(2). 434–438. 51 indexed citations

14.

Vermitsky, John‐Paul, et al.. (2006). Pdr1 regulates multidrug resistance in Candida glabrata: gene disruption and genome‐wide expression studies. Molecular Microbiology. 61(3). 704–722. 180 indexed citations

15.

Ernst, Erika J. & P. David Rogers. (2005). Antifungal agents: methods and protocols.. Humana Press eBooks. 18 indexed citations

16.

Barker, Katherine S., et al.. (2005). Coculture of THP‐1 Human Mononuclear Cells withCandida albicansResults in Pronounced Changes in Host Gene Expression. The Journal of Infectious Diseases. 192(5). 901–912. 38 indexed citations

17.

Kusch, Harald, Kajal Biswas, Susanne Engelmann, et al.. (2004). A proteomic approach to understanding the development of multidrug-resistant Candida albicans strains. Molecular Genetics and Genomics. 271(5). 554–565. 35 indexed citations

18.

Agarwal, Ameeta K., P. David Rogers, Scott R. Baerson, et al.. (2003). Genome-wide Expression Profiling of the Response to Polyene, Pyrimidine, Azole, and Echinocandin Antifungal Agents in Saccharomyces cerevisiae. Journal of Biological Chemistry. 278(37). 34998–35015. 169 indexed citations

19.

Cleary, John D., et al.. (2003). Effects of Amphotericin B and Caspofungin on Histamine Expression. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 23(8). 966–973. 16 indexed citations

20.

Rogers, P. David, Robert Krämer, Stanley W. Chapman, & John D. Cleary. (1999). Amphotericin B–Induced Interleukin‐1β Expression in Human Monocytic Cells is Calcium and Calmodulin Dependent. The Journal of Infectious Diseases. 180(4). 1259–1266. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact